Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Index funds hold a selection of securities that mirror a target index. This piece breaks down the inside: holdings, risk controls, and fees.
13,896 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Salesforce is a powerhouse, but big questions remain about margins and AI-driven pricing. This piece explains why I’m...
A specialized REIT with cannabis-related tenants moved higher in today’s session. This article breaks down the factor...
Income-focused investors are tuning in to Energy Transfer for a high-yield dividend and steady growth. This guide exp...
PSEG's steady, regulated core supports its payout, but 2025 earnings hinge on rate cases, fuel costs, and clean energ...
Two years of rapid expansion can propel small innovators into the spotlight. This guide breaks down how to spot real ...
As volatility returns, smart investors ask which asset will shield wealth the best. This guide compares gold, silver,...
Oil markets swing as Middle East tensions deepen, intensifying supply concerns. In this environment, energy investors...
A sudden Medicare policy shift sparked worry for retirees. Lawmakers paused the cut, but only temporarily, leaving yo...
Lucid has set a production target, but many investors wonder if the pace will match the plan. This deep dive explains...
When headlines clash with court drama, money follows. This piece explains how public perception can tilt brand value ...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...